Offer - Urjas Oil for just ₹ 1 X
Arpimune ME 100 Mg Capsule is a prescription drug, available for use as Capsule. Primarily, it is used for the treatment of Psoriasis, Liver transplant. The alternative uses of Arpimune ME 100 Mg Capsule have also been explained below.
The optimal dosage of Arpimune ME 100 Mg Capsule is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Arpimune ME 100 Mg Capsule are Increased hair growth, Loss of appetite. Apart from the aforementioned side effects, Arpimune ME 100 Mg Capsule can also lead to other problems, which have been listed below. These side effects of Arpimune ME 100 Mg Capsule are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Arpimune ME 100 Mg Capsule's effect during pregnancy is Severe and Severe while nursing. In addition, Arpimune ME 100 Mg Capsule's effects on the liver, heart and kidney are discussed below in the Arpimune ME 100 Mg Capsule related warnings section.
Arpimune ME 100 Mg Capsule can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Arpimune ME 100 Mg Capsule in conditions like Liver Disease. Some other conditions that can be affected by Arpimune ME 100 Mg Capsule are listed in the contraindications section below.
Additionally, Arpimune ME 100 Mg Capsule may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Arpimune ME 100 Mg Capsule is safe while driving, and is addiction.
Arpimune ME 100 Mg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Arpimune ME 100 Mg Capsule safe for pregnant women?
Pregnant women may get severe side effects after taking Arpimune ME. If you are pregnant, do not take Arpimune ME without a doctor's advice.
Is the use of Arpimune ME 100 Mg Capsule safe during breastfeeding?
Arpimune ME should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Arpimune ME 100 Mg Capsule on the Kidneys?
Arpimune ME has very mild side effects on the kidneys.
What is the effect of Arpimune ME 100 Mg Capsule on the Liver?
Side effects of Arpimune ME rarely affect the liver.
What is the effect of Arpimune ME 100 Mg Capsule on the Heart?
The heart can be affected by Arpimune ME. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Arpimune ME 100 Mg Capsule unless your doctor advises you to do so -
Is this Arpimune ME 100 Mg Capsule habit forming or addictive?
No, there is no any evidence that Arpimune ME 100 Mg Capsule is addictive.
Interaction between Food and Arpimune ME 100 Mg Capsule
There is no information on the effects of taking Arpimune ME 100 Mg Capsule with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Arpimune ME 100 Mg Capsule
No research has been done on this till date. Therefore, it is not known what the effect of taking Arpimune ME 100 Mg Capsule with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 879-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380